| Sources | Names Used |
|---|---|
| GDSC1000 | HG-5-88-01 |
| PharmacoGx | HG-5-88-01 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RSPRY1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | DIO2 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | ZNF518B | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | SPA17 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | CD55 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | PLCG2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | HOXA1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | PPOX | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | MAGEE2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | ARID4B | GDSC1000 | pan-cancer | AAC | 0.083 | 0.09 |
